Wall Street Analysts Believe Apogee Therapeutics Inc. (APGE) Could Rally 134%: Here's is How to Trade

Core Viewpoint - Apogee Therapeutics Inc. (APGE) has seen a 24.1% increase in share price over the past four weeks, closing at $40.12, with analysts suggesting a potential upside of 134% based on a mean price target of $93.88 [1] Price Targets - The average price target from eight analysts ranges from a low of $78 to a high of $116, with a standard deviation of $11.05, indicating a potential increase of 94.4% to 189.1% from the current price [2] - A low standard deviation suggests a high degree of agreement among analysts regarding the stock's price movement [9] Analyst Sentiment - Analysts have shown increasing optimism about APGE's earnings prospects, with a strong consensus on revising EPS estimates higher, which correlates with potential stock price increases [11] - The Zacks Consensus Estimate for the current year has remained stable, with no negative revisions, indicating positive sentiment [12] Zacks Rank - APGE holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting a strong potential for upside [13]